The New Ethical Frontier: DIY Eugenics
By Michael Cook,
MercatorNet
| 05. 21. 2015
Untitled Document
The single most controversial development in biology in 2015 is a relatively cheap, easily manipulated technology for modifying the human genome.
Called Crispr, this tool allows scientists to “edit” the genome by deleting or adding DNA sequences. In just a couple of years, frenetic activity in labs around the world has taught scientists how to target and activate or silence specific genes. The implications for plant, animal and human biology are immense. For humans, Crispr opens up an panorama of dramatic cures and even enhancing the human genome.
But it is also quite troubling. Gene editing with Crispr only got started in 2013, but within two years position papers on ethical issues were already starting to flow.
Tinkering with the human germline has been off-limits for decades even if the mind-boggling experiments basically took place in the realm of science fiction. Since the 1970s there has been a consensus that scientists should not “play God” by creating “designer babies”. This was been codified in UNESCO’s 1997 Universal Declaration on the Human Genome and Human Rights, which implies...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...